NCT07674797

Brief Summary

To examine how we can provide supportive care for patients with advanced cancer better tailored to their needs

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
93mo left

Started Nov 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

November 22, 2026

Expected
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2032

2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2034

Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

5.6 years

First QC Date

June 24, 2026

Last Update Submit

June 24, 2026

Conditions

OncologicPalliative CareRemote MonitoringElectronic AssessmentsTelehealth

Outcome Measures

Primary Outcomes (1)

  • Self Report Questionnaire

    Through study completion; an average of 1 year

Study Arms (3)

Dose Dense Timely SPC

EXPERIMENTAL
Other: Questionnaire and Physical Exam

Enhanced UC

EXPERIMENTAL
Other: Questionnaire and Physical Exam

Stadard Timely SPC

EXPERIMENTAL
Other: Questionnaire and Physical Exam

Interventions

Questionnaire and Physical ExamOTHER

Patient will complete questionnaires and physical exams

Dose Dense Timely SPCEnhanced UCStadard Timely SPC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Cognitive impairment in the opinion of the oncologist necessitating need for a surrogate decision making.
  • Previously seen by SPC team at UT MD Anderson

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Surveys and QuestionnairesRestraint, Physical

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthBehavior ControlTherapeuticsImmobilization

Study Officials

  • David Hui, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Hui, MD

CONTACT

713-792-6258dhui@mdanderson.org

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2026

First Posted

June 30, 2026

Study Start (Estimated)

November 22, 2026

Primary Completion (Estimated)

June 30, 2032

Study Completion (Estimated)

June 30, 2034

Last Updated

June 30, 2026

Record last verified: 2026-06

Locations

US(1)